EspaƱol
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 35 for your search:
Drug:  brentuximab vedotin
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: C25006, 2012-004128-39, U1111-1154-9784, REec-2014-0649, 13/NI/0072, NCT01909934

2.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: C25007, 2013-000232-10, U1111-1154-2250, NMRR-13-1246-18099, REec-2014-0619, NCT01990534

3.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SGN35-014, 2012-002751-42, NCT01777152

4.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Health services research, Supportive care, Treatment
Status: Active
Age: 18 and younger
Sponsor: NCI
Protocol IDs: NCI-2014-01223, AHOD1331, NCT02166463

5.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00046, AMC-085, U01CA121947, NCT01771107

6.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 13 to 30
Sponsor: NCI
Protocol IDs: NCI-2013-00107, COG-AHOD1221, AHOD1221, UM1CA097452, NCT01780662

7.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: NU 12H09, NCI-2012-03090, STU00072695, NCT01805037

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UPCC 17413, NCT01994850

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2013-0706, NCI-2014-01114, NCT02096042

10.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 45 and under
Sponsor: Other
Protocol IDs: NYMC 564, NCT02098512

11.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 9111, NCI-2014-01782, P30CA015704, NCT02227199

12.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: BRESHAP-GELTAMO.LH-2013, 2014-000835-17, NCT02243436

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: FM-12-GCT01, 2012-004508-36, NCT01851200

14.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and under
Sponsor: Other
Protocol IDs: HLHR13, NCI-2013-01123, NCT01920932

15.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SGN35-017, NCT01925612

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-2013-02167, COG-ANHL12P1, ANHL12P1, U10CA180886, U10CA098543, NCT01979536

17.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2013-0351, NCI-2014-01593, NCT02169505

18.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 60 and over
Sponsor: Other
Protocol IDs: B-CAP, NCT02191930

19.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 60 and over
Sponsor: Other
Protocol IDs: FIL BVHD01, NCT02227433

20.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: FIL_BRidge, NCT02244021

21.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 75
Sponsor: Other
Protocol IDs: SMC 2014-04-059, NCT02280785

22.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 60
Sponsor: Other
Protocol IDs: BREACH, NCT02292979

23.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 65
Sponsor: Other
Protocol IDs: BRAPP2, NCT02298283

24.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 1 to 29
Sponsor: Other
Protocol IDs: NYMC-568, NCT02398240

25.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 13-040, NCT01830777
1   
New Search